Skip to main content
Premium Trial:

Request an Annual Quote

Keygene Licenses Genetic ID Tech to Ghent University Microbiology Lab

NEW YORK (GenomeWeb News) — Keygene has licensed some of its genomic technology to a research group in Ghent University in Belgium, Keygene said Tuesday.
 
The five-year, non-exclusive agreement allows the Belgian Coordinated Collection of Microorganisms at the Laboratory for Microbiology at Ghent University, or BCCM/LMG, to use Keygene’s AFLP technology to “extend its genetic database” and “serve its customers with AFLP typing of bacterial stains.”
 
AFLP is a DNA marker technology for genome analysis, transcript profiling, and genetic analysis. BCCM/LMG manages bacterial strains for the Belgian BCCM Consortium.
 
Ghent University used the technology in the early 1990s to build its bacterial database, said BCCM/LMG director Paul de Vos.
 
Financial terms of the agreement were not released.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.